Health-care companies rose after strong earnings.
Shares of vaccine maker Moderna surged after it reported a 9% increase in second-quarter sales, even as issues with surplus vaccine doses weighed on profit.
CVS Health shares rose after the drug-store chain boosted its profit projection for the year after reporting an 11% increase in second-quarter sales, lifted by growth in both its insurance and pharmacy operations.
Biotech concern Gilead Sciences rose sharply after it boosted its sales projection for 2022, citing strong demand for HIV and oncology products.
Alnylam Pharmaceuticals rallied by more than 40% after the company disclosed promising results in a late-stage study of a key drug for a protein buildup condition.
Charles River Laboratories fell after the provider of services to drug developers and other health-care companies posted quarterly earnings short of some investors' targets.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
08-03-22 1744ET
